The Impact of Demographics and Disease Prevalence on Market Growth

The US Percutaneous Coronary Intervention (PCI) Market is experiencing a powerful growth trajectory, which is largely attributable to the country's evolving demographic profile and the high prevalence of cardiovascular diseases. The number of Americans aged 65 and older is projected to rise to 73.1 million by 2030, representing nearly one-fifth of the total population. This demographic segment is disproportionately affected by coronary artery disease (CAD), making them a primary driver of demand for PCI procedures. According to the CDC, approximately 20.1 million US adults were living with CAD in 2020. This widespread prevalence, combined with an increasing emphasis on early diagnosis and proactive treatment, ensures a steady and growing patient pool for interventional cardiologists. The aging population not only requires more procedures but also benefits from the minimally invasive nature of PCI, which is associated with faster recovery times and reduced hospital stays compared to traditional open-heart surgery.

Link: Find out how demographics are influencing the market

FAQs

• How does the aging population drive the market? The number of Americans over 65, a group highly susceptible to heart disease, is growing rapidly, leading to a higher demand for PCI procedures.

• What is the prevalence of CAD in the US? Coronary Artery Disease affects over 20 million adults in the US, creating a large patient base for the PCI market.